# Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia

> **NCT02339038** · PHASE4 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 600 (actual)

## Conditions studied

- HCV HIV

## Interventions

- **DRUG:** Ledipasvir 90 mg and Sofosbuvir 400 mg

## Key facts

- **NCT ID:** NCT02339038
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-07
- **Primary completion:** 2016-06-15
- **Final completion:** 2018-07-13
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339038, "Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT02339038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*